Virtual Short Course Offers New Insights for Corrosion Prevention and Sustainability of Biomedical Implants and Devices

What Kind of Equipment is Used to Analyze DNA?

Below are some of a few basic processes followed throughout DNA testing. The general procedure entails:  • Isolating DNA from a sample containing the needed...

mJOULE Launches in the United Kingdom Reports Sciton

"Sciton is dedicated to worldwide support and growth. We continue to demonstrate our commitment to developing high quality devices and marketing efforts for our physician and medspa partners worldwide." says Lacee J. Naik, Vice President of Marketing and Public Relations.

FDA Issues Draft Guidance on Remanufacturing and Discussion Paper Seeking Feedback on Cybersecurity Servicing of Medical Devices

With this in mind, the FDA is issuing today's draft guidance to help clarify whether activities performed on medical devices are likely remanufacturing as well as a discussion paper on cybersecurity servicing of devices.

AMPP’s Corrosion Technical Series is now offering a new 6-hour short course on corrosion prevention in metallic biomaterials and biomedical devices.

What happens to metallic implants and medical devices when placed in the human body?

The biological interaction between metallic biomaterials and corrosion is endlessly complex and comes with potentially beneficial or dangerous effects.

In this short course, a panel of biomaterials and tribocorrosion experts from the academic, regulatory and industry sectors will discuss several facets of corrosion’s impacts in metallic biomaterials and biomedical devices; from those intended to corrode such as biodegradable stents and sutures/clips, to those meant to last such as hip and knee implants.

Attendees will leave this course with a foundational knowledge of the interface between metals and biology, the types of alloys used in biomedical devices and implants, testing and remediation methods, and the types of degradation that can impact the service life of these devices.

Featured lecturers include:

  • Jeremy Gilbert, Ph.D., FBSE, FAIMBE, Hansjorg Wyss Endowed Chair, Professor of Bioengineering Clemson University and the Director, Clemson – MUSC Bioengineering Program Medical University of South Carolina
  • Bruce Pound, Senior Managing Scientist and Medical Devices Consultant at Exponent
  • Michael Bryant, Associate Professor, University of Leeds, United Kingdom
  • Stephanie ​Smith, PhD, Biomedical Engineer, Intracolumnar Spinal Devices Team Food & Drug Administration

This short course is offered in a live, interactive, virtual format with knowledge checks and Q&A sessions to ensure students gain a thorough understanding of the course material. At the end, participants can earn a certificate of completion and professional development hours (PDHs) to demonstrate their understanding of the materials covered in the course.

Corrosion Technical Series: Corrosion Impacts in Renewable Energy

June 15-16, 2021
9 a.m. – 12:00 p.m. CDT each day

For more information and to register, visit https://www.nace.org/education/courses-by-program/corrosion-technical-series/corrosion-impacts-biomedical-devices

ABOUT AMPP
The Association for Materials Protection and Performance (AMPP) is focused on the protection of assets and the performance of industrial and natural materials. AMPP was created when NACE International and SSPC: The Society for Protective Coatings united after more than 145 combined years of expertise and service to industry and individual members worldwide. Today, AMPP is the world’s largest corrosion control and protective coatings organization serving more than 40,000 members in 130 countries. AMPP is headquartered in the United States with offices in Houston and Pittsburgh, and additional offices in Brazil, Canada, China, Dubai (training center), Malaysia, Saudi Arabia, and the United Kingdom. www.ampp.org

 

spot_img

DON'T MISS

Hyperfine Adds Medtech Leader and Visionary Scott Huennekens as Executive Chairman

Mr. Huennekens’ public boards include Chairman of Acutus Medical (IPO August 2020); Chairman of Envista (IPO September 2019); and board member of Nuvasive. He also serves as a board member and past Chairman of the Medical Device Manufacturer’s Association (MDMA).

One Drop Reports Carrie Siragusa, CPA Appointed VP of Commercial Strategy, Biosensor

Formerly Head of Innovation and Diabetes Portfolio at Sanofi, Siragusa will be part of a team bringing a multi-analyte dermal sensor (biosensor) with continuous health sensing capabilities to market with a mission to provide broader access to continuous glucose monitoring.

Barbara Moorhouse Appointed as Medica Non-Executive Director

Barbara has extensive business and management experience in the private, public, and regulated sectors.

Subscribe to Medical Device News Magazine here.

Related Articles